These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 303141
1. Interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and morphometric bone changes in anticonvulsant osteomalacia. Therapeutic effect of vitamin D2. Melsen F, Mosekilde L, Christensen MS, Lund B, Sorensen OH. Calcif Tissue Res; 1977 May; 22 Suppl():473-8. PubMed ID: 303141 [No Abstract] [Full Text] [Related]
2. Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia. Mosekilde L, Melsen F, Christensen MS, Lund B, Sorenson OH. Acta Med Scand; 1977 May; 201(4):303-7. PubMed ID: 300547 [Abstract] [Full Text] [Related]
3. The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia. Mosekilde L, Christensen MS, Lund B, Sorensen OH, Melsen F. Acta Endocrinol (Copenh); 1977 Mar; 84(3):559-65. PubMed ID: 576530 [Abstract] [Full Text] [Related]
4. Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia. Christiansen C, Rodbro P, Munck O. Br Med J; 1975 May 17; 2(5967):363-5. PubMed ID: 165857 [Abstract] [Full Text] [Related]
6. Initial and maintenance dose of vitamin D2 in the treatment of anticonvulsant osteomalacia. Christiansen C, Rodbro P. Acta Neurol Scand; 1974 May 17; 50(5):631-41. PubMed ID: 4547902 [No Abstract] [Full Text] [Related]
18. Effect of phenytoin on bone and vitamin D metabolism. Bell RD, Pak CY, Zerwekh J, Barilla DE, Vasko M. Ann Neurol; 1979 Apr 17; 5(4):374-8. PubMed ID: 220903 [Abstract] [Full Text] [Related]